Literature DB >> 10839609

Mixed endocrine-exocrine tumors of the gastrointestinal tract.

C Capella1, S La Rosa, S Uccella, P Billo, M Cornaggia.   

Abstract

Mixed endocrine-exocrine tumors of the gastrointestinal tract are rare neoplasms, which have been reported in the literature mainly as case reports and have been designated with a various and rather confusing terminology. In this review, on the basis of personally studied cases and of the analysis of cases reported in the literature, we have tried to identify types of mixed endocrine-exocrine tumors showing different clinicopathologic and biological characteristics. We have also tried to group the different clinicopathologic entities in prognostic classes which include: benign, low-grade, intermediate grade, and high-grade malignant mixed endocrine-exocrine tumors. The criteria for identifying the various types of mixed endocrine-exocrine tumors are extensively discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839609

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  32 in total

1.  Mixed exocrine and endocrine carcinoma in the stomach: a case report.

Authors:  Han Hong Lee; Chan Kwon Jung; Eun Sun Jung; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

2.  Rapid four-month growth of an early-stage adenocarcinoma of the colon with neuroendocrine characteristics.

Authors:  Shigetoshi Hosaka; Kenji Matsuzawa; Kazutoshi Maruyama; Hiroyoshi Ota; Taui Akamatsu; Kendo Kiyosawa
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

3.  Images in endocrine pathology : oncocytic differentiation in a mixed adenoneuroendocrine carcinoma of the colon.

Authors:  Alessandro Marando; Emanuele Dainese; Stefano La Rosa; Carlo Capella
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 4.  Concurrent insulinoma and pancreatic adenocarcinoma: report of a rare case and review of the literature.

Authors:  Panagiotis G Athanasopoulos; George Polymeneas; Dionysios Dellaportas; George Mastorakos; Evi Kairi; Dionysios Voros
Journal:  World J Surg Oncol       Date:  2011-01-25       Impact factor: 2.754

5.  Early precursor of mixed endocrine-exocrine tumors of the gastrointestinal tract: histologic and molecular correlations.

Authors:  Fateh Bazerbachi; Taher R Kermanshahi; Carmela Monteiro
Journal:  Ochsner J       Date:  2015

Review 6.  Pathologic research update of colorectal neuroendocrine tumors.

Authors:  Shu-Juan Ni; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

7.  Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity.

Authors:  Shayna Brathwaite; Jonathan Rock; Martha M Yearsley; Tanios Bekaii-Saab; Lai Wei; Wendy L Frankel; John Hays; Christina Wu; Sherif Abdel-Misih
Journal:  Ann Surg Oncol       Date:  2016-03-10       Impact factor: 5.344

8.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

Review 9.  Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature.

Authors:  Stefano La Rosa; Barbara Bernasconi; Donata Micello; Giovanna Finzi; Carlo Capella
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 10.  Mixed pituitary adenoma/craniopharyngioma: clinical, morphological, immunohistochemical and ultrastructural study of a case, review of the literature, and pathogenetic and nosological considerations.

Authors:  Giovanna Finzi; Michele Cerati; Alessandro Marando; Cesare Zoia; Fabio Ferreli; Giustino Tomei; Paolo Castelnuovo; Stefano La Rosa; Carlo Capella
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.